Infection and esophageal cancer

Annals of the New York Academy of Sciences

Volumn 1325, Issue 1, 2014, Pages 187-196

  Al Haddad, Sahar ^a   El Zimaity, Hala ^b   Hafezi Bakhtiari, Sara ^c   Rajendra, Shanmugarajah ^d,e,f   Streutker, Catherine J ^a   Vajpeyi, Rajkumar ^c   Wang, Bin ^d,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

Author keywords

Epstein Barr; Esophageal adenocarcinoma; Helicobacter pylori; HPV; Microbiota; Mucin; OESO

Indexed keywords

MUCIN; MUCIN 2; MUCIN 5AC; MUCIN 6;

ARTICLE; BACTERIAL INFECTION; BARRETT ESOPHAGUS; BIOTA; CANCER RISK; EPSTEIN BARR VIRUS INFECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; ESOPHAGUS DYSPLASIA; GENOTYPE; HEART CARCINOMA; HELICOBACTER PYLORI; HUMAN; LOWER ESOPHAGUS SPHINCTER; MICROFLORA; NEXT GENERATION SEQUENCING; NONHUMAN; OROPHARYNX CANCER; PROTEIN EXPRESSION; WART VIRUS; ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; ESOPHAGEAL NEOPLASMS; FRANCE; HELICOBACTER INFECTIONS; MICROBIOLOGY; PAPILLOMAVIRUS INFECTIONS; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; HUMAN HERPESVIRUS 4; HUMAN PAPILLOMAVIRUS;

ANIMALS; EPSTEIN-BARR VIRUS INFECTIONS; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HUMANS; MICROBIOTA; PAPILLOMAVIRUS INFECTIONS; PARIS;

EID: 84925190382     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12530     Document Type: Article

References (69)

1. Hollingsworth, M.A. & B.J. Swanson . 2004. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4: 45-60.
2. Hatayama, H., J. Iwashita, A. Kuwajima & T. Abe . 2007. The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. Biochem. Biophys. Res. Comm. 356: 599-603.
3. Dohrman, A., S. Miyata, M. Gallup, et al. 1998. Mucin gene (MUC2 and MUC5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim. et. Biophys. Acta. 1406: 251-159.
4. Lau, S.K., L.M. Weiss & P.G. Chu . 2004. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites. Anat. Pathol. 122: 61-69.
5. Mejias-Luque, R., S.K. Linden, M. Garrido, et al. 2010. Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors. Oncogene 29: 1753-1762.
6. Komatsu, M., S. Jepson, M.E. Arango, et al. 2001. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 20: 461-470.
7. Velcich, A., W. Yang, J. Heyer, et al. 2002. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295: 1726-1729.
8. Glickman, J.N., P.L. Blount, C.A. Sanches, et al. 2006. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus. Hum. Path. 37: 1304-1315.
9. Lederberg, J. 2001. 'Ome Sweet 'Omics-a genealogical treasury of words. The Scientist Vol. 15: Issue 7.
10. Wang, Z.K. & Y.S. Yang . 2013. Upper gastrointestinal microbiota and digestive diseases. World J. Gastroenterol. 19: 1541-1550.
11. Pei, Z., E.J Bini, L. Yang, et al. 2004. Bacterial biota in the human distal esophagus. Proc. Natl. Acad. Sci. USA 101: 4250-4255.
12. Yang, L., X. Lu, C.W. Nossa, et al. 2009. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137: 588-597.
13. Yang, L., F. Francois & Z. Pei . 2012. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin. Cancer Res. 18: 2138-2144.
14. O'Riordan, J.M., M.M. Abdel-latif, N. Ravi, et al. 2005. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am. J. Gastroenterol. 100: 1257-1264.
15. Calatayud, S., M.D. Barrachina, E. Garcia-Zaragoza, et al. 2001. Endotoxin inhibits gastric emptying in rats via a capsaicin-sensitive afferent pathway. Naunyn Schmiedebergs Arch. Pharmacol. 363: 276-280.
16. Fan, Y.P., S. Chakder, F. Gao & S. Rattan . 2001. Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G32-G42.
17. Syrjanen, K.J. 1982. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch. Geschwulstforsch 52: 283-292.
18. Koh, J.S. et al. 2008. No association of high risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by PCR. Dis. Esophagus. 21: 114-117.
19. Guo, F. et al. 2012. Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol. Biomarkers Prev. 21: 780-785.
20. Sitas, F. et al. 2012. InterSCOPE study: associations between esophageal squamous cell carcinoma and HPV serological markers. J. Natl. Cancer Inst. 104: 147-158.
21. Yong, F. et al. 2013. Human papillomavirus types 16 and 18 in esophageal squamous cell carcinoma: a meta-analysis. Ann. Epidemiol. 23: 726-734.
22. Liyanage, S.S. et al. 2013. The aetiological role of Human Papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis. PLoS One 8: e69238.
23. Rajendra, S. & P. Sharma . 2012. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap. Adv. Gastroenterol. 5: 285-299.
24. Rajendra, S. & I.K. Robertson . 2010. Similar immunogenetics of Barrett's oesophagus and cervical neoplasia: is HPV the common denominator? J. Clin. Pathol. 63: 1-3.
25. McLaughlin-Drubin, M.E., J. Meyers & K. Munger . 2012. Cancer associated human papillomaviruses. Curr. Opin. Virol. 2: 459-466.
26. Rajendra, S. et al. 2013. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma. Am. J. Gastroenterol. 108: 1082-1093.
27. Josefsson, A.M. et al. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2189-2193.
28. Si, H.X. et al. 2003. Viral load of HPV in esophageal squamous cell carcinoma. Int. J. Cancer 103: 496-500.
29. Deng, Z. et al. 2012. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Head Neck 35: 800-808.
30. Boshart, M. et al. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3: 1151-1157.
31. Saunier, M. et al. 2008. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J. Clin. Microbiol. 46: 3678-3685.
32. Wang, B. et al. 2013. Viral load and integration status of high-risk human papillomaviruses in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am. J. Gastroenterol. 108: 1814-1816.
33. Gonzalez, C.A., N. Sala & T. Rokkas . 2013. Gastric cancer: epidemiologic aspects. Helicobacter 18: 34-38.
34. Powell, J. & C.C. McConkey . 1990. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br. J. Cancer 62: 440-443.
35. Devesa, S.S., W.J. Blot & J.F. Fraumeni Jr. 1998. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053.
36. Schmassmann, A., M.G. Oldendorf & J.O. Gebbers . 2009. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur. J. Epidemiol. 24: 603-609.
37. Abrams, J.A., L. Gonsalves & A.I. Neugut . 2013. Diverging trends in the incidence of reflux-related and Helicobacter pylori-related gastric cardia cancer. J. Clin. Gastroenterol. 47: 322-327.
38. Koike, T., S. Ohara, H. Sekine, et al. 1999. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am. J. Gastroenterol. 94: 3468-3472.
39. Blaser, M.J. 1999. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J. Infect. Dis 179: 1523-1530.
40. Baldwin, D.N., B. Shepherd, P. Kraemer, et al. 2007. Identification of Helicobacter pylori genes that contribute to stomach colonization. Infect. Immun. 75: 1005-1016.
41. Kusters, J.G., A.H. van Vliet & E.J. Kuipers . 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19: 449-490.
42. Kudo, M., O. Gutierrez, H.M. El-Zimaity, et al. 2005. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J. Clin. Pathol. 58: 259-262.
43. Lin, J.T., L.Y. Wang, J.T. Wang, et al. 1995. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res. 15: 603-606.
44. Kamangar, F., Y.L. Qiao, M.J. Blaser, et al. 2007. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br. J. Cancer 96: 172-176.
45. Chen, M.J., D.C. Wu, J.M. Lin, et al. 2009. Etiologic factors of gastric cardiac adenocarcinoma among men in Taiwan. World J. Gastroenterol. 15: 5472-5480.
46. Wang, K., C.Q. Yang, L.P. Duan, et al. 2012. Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China. Tumori 98: 568-574.
47. Siewert, J.R. & H.J. Stein . 1998. Classification of adenocarcinoma of the oesophagogastric junction. Br. J. Surg. 85: 1457-1459.
48. Whiteman, D.C., P. Parmar, P. Fahey, et al. 2010. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 139: 73-83; quiz e11-72.
49. Kamangar, F., S.M. Dawsey, M.J. Blaser, et al. 2006. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J. Natl. Cancer Inst. 98: 1445-1452.
50. Talley, N.J., A.R. Zinsmeister, A. Weaver, et al. 1991. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst. 83: 1734-1739.
51. Ye, W., M. Held, J. Lagergren, et al. 2004. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Natl. Cancer Inst. 96: 388-396.
52. Nomura, A.M., L.N. Kolonel, K. Miki, et al. 2005. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J. Infect. Dis. 191: 2075-2081.
53. Sudraba, A., I. Daugule, D. Rudzite, et al. 2011. Performance of routine Helicobacter pylori tests in patients with atrophic gastritis. J. Gastrointestin. Liver Dis. 20: 349-354.
54. Islami, F., P. Sheikhattari, J.S. Ren & F. Kamangar . 2011. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma-a systematic review and meta-analysis. Ann. Oncol. 22: 754-760.
55. Huang, Q., X. Fan, A.T. Agoston, et al. 2011. Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients. Histopathology 59: 188-197.
56. Falush, D., T. Wirth, B. Linz, et al. 2003. Traces of human migrations in Helicobacter pylori populations. Science 299: 1582-1585.
57. Linz, B., F. Balloux, Y. Moodley, et al. 2007. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445: 915-918.
58. Moodley, Y., B. Linz, Y. Yamaoka, et al. 2009. The peopling of the Pacific from a bacterial perspective. Science 323: 527-530.
59. Dent, J., H.B. El-Serag, M.A. Wallander & S. Johansson . 2005. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54: 710-717.
60. Baumforth, K.R., L.S. Young, K.J Flavell, et al. 1999. The Epstein-Barr virus and its association with human cancers. Mol. Pathol. 52: 307-322.
61. Lo, A.K., K.W. Lo, S.W. Tsao, et al. 2006. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8: 173-180.
62. Terada, T. 2013. Epstein-Barr virus associated lymphoepithelial carcinoma of the esophagus. Int. J. Clin. Exp. Med. 6: 219-226.
63. Valbuena, J.R., Y. Retamal, C. Bernal, et al. 2007. Epstein-Barr Virus-associated Primary Lymphoepitheliomalike Carcinoma of the Esophagus. Diagn. Mol. Pathol. 16: 27-31.
64. Wang, L.S., K.C. Chow, Y.C. Wu, et al. 1999. Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan. Am. J. Gastroenterol. 94: 2834-2839.
65. Wu, M.Y., X.Y. Wu & C.X. Zhuang . 2005. Detection of HSV and EBV in esophageal carcinomas from a high-incidence area in Shantou China. Dis. Esophagus 18: 46-50.
66. Zhang, D.H., Q.Y. Zhang, C.O. Hong, et al. 2011. Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study. Oncol. Rep. 25: 1731-1738.
67. Sunpaweravong, S., W. Mitarnun & P. Puttawibul . 2005. Absence of Epstein-Barr virus in esophageal squamous cell carcinoma. Dis. Esophagus. 18: 398-399.
68. Chen, P., C. Pan, W. Hsu, et al. 2003. Epstein-Barr virus-associated lymphoepithelioma-like carcinoma of the esophagus. Hum. Pathol. 34: 407-411.
69. Wang, J., A. Noffsinger, G. Stemmermann, et al. 1999. Esophageal squamous cell carcinomas arising in patients from a high-risk area of north China lack an association with Epstein-Barr virus. Cancer Epidemiol. Biomarkers Prev. 8: 1111-1114.